Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder

Vaccine

Volumn 33, Issue 21, 2015, Pages 2511-2516

  Uno, Yota ^a,b   Uchiyama, Tokio ^b,c   Kurosawa, Michiko ^d   Aleksic, Branko ^a   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yokohama Psycho Developmental Clinic   (Japan)

^c FUKUSHIMA UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autism spectrum disorder; Case control study; Environmental factors; Measles Mumps Rubella vaccine; Risk factor; Thimerosal

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; THIMEROSAL CONTAINING VACCINE; THIOMERSAL; UNCLASSIFIED DRUG; VACCINE; PRESERVATIVE;

AGE; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; HUMAN; INFANT; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; VACCINATION; ADULT; AUTISM SPECTRUM DISORDER; CHEMICALLY INDUCED; FEMALE; MALE; RISK ASSESSMENT;

ADULT; AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PRESERVATIVES, PHARMACEUTICAL; RISK ASSESSMENT; THIMEROSAL;

EID: 84928582327     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.036     Document Type: Article

References (49)

1. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
2. Levy S.E., Mandell D.S., Schultz R.T. Autism. Lancet 2009, 374:1627-1638.
3. Lichtenstein P., Carlstrom E., Rastam M., Gillberg C., Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010, 167:1357-1363.
4. Sandin S., Lichtenstein P., Kuja-Halkola R., Larsson H., Hultman C.M., Reichenberg A. The familial risk of autism. JAMA 2014, 311:1770-1777.
5. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014, 383:896-910.
6. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351:637-641.
7. The Editors of The Lancet Retraction-Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010, 375:445.
8. Kawashima H., Mori T., Kashiwagi Y., Takekuma K., Hoshika A., Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 2000, 45:723-729.
9. Uhlmann V., Martin C.M., Sheils O., Pilkington L., Silva I., Killalea A., et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002, 55:84-90.
10. Bernard S., Enayati A., Redwood L., Roger H., Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses 2001, 56:462-471.
11. Offit P.A. Vaccines and autism revisited - the Hannah Poling case. N Engl J Med 2008, 358:2089-2091.
12. The American Academy of Pediatrics and The United States Public Health Service Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics 1999, 104:568-569.
13. DeStefano F., Bhasin T.K., Thompson W.W., Yeargin-Allsopp M., Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta. Pediatrics 2004, 113:259-266.
14. Smeeth L., Cook C., Fombonne E., Heavey L., Rodrigues L.C., Smith P.G., et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004, 364:963-969.
15. DeWilde S., Carey I.M., Richards N., Hilton S.R., Cook D.G. Do children who become autistic consult more often after MMR vaccination. Br J Gen Pract 2001, 51:226-227.
16. Price C.S., Thompson W.W., Goodson B., Weintraub E.S., Croen L.A., Hinrichsen V.L., et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010, 126:656-664.
17. Taylor L.E., Swerdfeger A.L., Eslick G.D. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 2014, 32:3623-3629.
18. Yoshimasu K., Kiyohara C., Takemura S., Nakai K. A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood. Neurotoxicology 2014, 44C:121-131.
19. Uno Y., Uchiyama T., Kurosawa M., Aleksic B., Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 2012, 30:4292-4298.
20. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008, 83:445-456.
21. Siva N. Thiomersal vaccines debate continues ahead of UN meeting. Lancet 2012, 379:2328.
22. Brown K.F., Long S.J., Ramsay M., Hudson M.J., Green J., Vincent C.A., et al. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine 2012, 30:1855-1864.
23. Casiday R., Cresswell T., Wilson D., Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006, 24:177-184.
24. Cassell J.A., Leach M., Poltorak M.S., Mercer C.H., Iversen A., Fairhead J.R. Is the cultural context of MMR rejection a key to an effective public health discourse. Public Health 2006, 120:783-794.
25. Hilton S., Hunt K., Petticrew M. MMR: marginalised, misrepresented and rejected? Autism: a focus group study. Arch Dis Child 2007, 92:322-327.
26. Offit P.A., Coffin S.E. Communicating science to the public: MMR vaccine and autism. Vaccine 2003, 22:1-6.
27. Stephen D., Sugarman S.D. Cases in vaccine court - legal battles over vaccines and autism. N Engl J Med 2007, 357:1275-1277.
28. Wing L., Leekam S.R., Libby S.J., Gould J., Larcombe M. The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. J Child Psychol Psychiatry 2002, 43:307-325.
29. Leekam S.R., Libby S.J., Wing L., Gould J., Taylor C. The Diagnostic Interview for Social and Communication Disorders: algorithms for ICD-10 childhood autism and Wing and Gould autistic spectrum disorder. J Child Psychol Psychiatry 2002, 43:327-342.
30. Kent R.G., Carrington S.J., Le Couteur A., Gould J., Wing L., Maljaars J., et al. Diagnosing Autism Spectrum Disorder: who will get a DSM-5 diagnosis?. J Child Psychol Psychiatry 2013, 54:1242-1250.
31. Sugiura A., Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 1991, 10:209-213.
32. Kunugi H., Nanko S., Takei N., Saito K., Murray R.M., Hirose T. Perinatal complications and schizophrenia. Data from the Maternal and Child Health Handbook in Japan. J Nerv Ment Dis 1996, 184:542-546.
33. Ohara K., Tanabu S., Yoshida K., Sato Y., Shibuya H. Obstetric complications in siblings of Japanese schizophrenics: data from the Maternal and Child Health Handbook. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:617-620.
34. Honda H., Shimizu Y., Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 2005, 46:572-579.
35. Uchiyama T., Kurosawa M., Inaba Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord 2007, 37:210-217.
36. Brugha T.S., McManus S., Bankart J., Scott F., Purdon S., Smith J., et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 2011, 68:459-465.
37. Kim Y.S., Leventhal B.L., Koh Y.J., Fombonne E., Laska E., Lim E.C., et al. Prevalence of Autism Spectrum Disorders in a total population sample. Am J Psychiatry 2011, 168:904-912.
38. Taylor B., Jick H., Maclaughlin D. Prevalence and incidence rates of autism in the UK: time trend from 2004-2010 in children aged 8 years. BMJ Open 2013, 3:e003219.
39. Vastag B. Congressional autism hearings continue: no evidence MMR vaccine causes disorder. JAMA 2001, 285:2567-2569.
40. Christensen J., Gronborg T.K., Sorensen M.J., Schendel D., Parner E.T., Pedersen L.H., et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013, 309:1696-1703.
41. Ciesielski T., Weuve J., Bellinger D.C., Schwartz J., Lanphear B., Wright R.O. Cadmium exposure and neurodevelopmental outcomes in U.S. children. Environ Health Perspect 2012, 120:758-763.
42. Gardener H., Spiegelman D., Buka S.L. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009, 195:7-14.
43. Guinchat V., Thorsen P., Laurent C., Cans C., Bodeau N., Cohen D. Pre-, peri- and neonatal risk factors for autism. Acta Obstet Gynecol Scand 2012, 91:287-300.
44. Ho M., Garnett S.P., Baur L., Burrows T., Stewart L., Neve M., et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis. Pediatrics 2012, 130:e1647-e1671.
45. Rai D., Lee B.K., Dalman C., Golding J., Lewis G., Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013, 346:f2059.
46. Volk H.E., Lurmann F., Penfold B., Hertz-Picciotto I., McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 2013, 70:71-77.
47. Zerbo O., Iosif A.M., Walker C., Ozonoff S., Hansen R.L., Hertz-Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 2013, 43:25-33.
48. Zerbo O., Qian Y., Yoshida C., Grether J.K., Van de Water J., Croen L.A. Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord 2013, 10.1007/s10803-013-2016-3.
49. State M.W., Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 2011, 14:1499-1506.